These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5568700)

  • 21. [Preventive and curative silicotropic effect of polyvinylpyridine-N-oxide in liver and spleen tests].
    Hennies H; Eger K; Eger W
    Beitr Silikoseforsch; 1967; 93():15-32. PubMed ID: 6072453
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis].
    Deĭnega VG; Bolonova LN; Sukhanov VV; Zemliakova LF; Tkachuk SV
    Gig Tr Prof Zabol; 1977; (6):25-8. PubMed ID: 892540
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of inhalations of polyvinylpyridine-N-oxide on the development of experimental silicosis].
    Rodkina BS; Bolonova LN
    Farmakol Toksikol; 1979; 42(1):81-4. PubMed ID: 421895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Further study of the antisilicotic effectiveness of polypyridylethylmethacrylate phosphate].
    Aronova GV; Katsnel'son BA
    Gig Tr Prof Zabol; 1977; (6):49-51. PubMed ID: 892546
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of polyvinylpyridine N-oxide on pulmonary tissue scleroproteins in experimental silicosis].
    Gel'fon IA
    Gig Tr Prof Zabol; 1978 Sep; (9):54. PubMed ID: 689462
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental silicosis caused by the dust from extra-pure crystalline silicon and the effect of polyvinylpyridine N-oxide on its course].
    Golodnikov IuN
    Gig Tr Prof Zabol; 1978 Dec; (12):31-6. PubMed ID: 720881
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antisilicotic effectiveness of a Soviet polyvinoxide].
    Aronova GV; Katsnel'son BA
    Gig Tr Prof Zabol; 1974 Oct; (10):48-9. PubMed ID: 4465173
    [No Abstract]   [Full Text] [Related]  

  • 28. [Secondary effects of parenterally administered polymeric compounds (polyvinylpyridine-N-oxide)].
    Lushnikova GA; Dubovik BV; Shadurskii KS; Lushnikov EF
    Farmakol Toksikol; 1972; 35(3):363-6. PubMed ID: 5047309
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of polyvinylpyridine N-oxide on individual lung tissue indices in experimental silicosis].
    Mukhina ST; Veretinskaia AG
    Gig Tr Prof Zabol; 1974 Oct; (10):33-5. PubMed ID: 4465165
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hydroxyproline content in the peptide makeup of the lung tissue of animals with experimental silicosis].
    Rodkina BS
    Ukr Biokhim Zh; 1974; 46(3):393-7. PubMed ID: 4836947
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antisilicotic properties of polyethylene-piperazine N-oxide--a new polymeric compound].
    Kupina LM; Ivanova AS; Fedorova VI; Nekrasov AV; Puchkova NG; Tarasenko PK
    Farmakol Toksikol; 1978; 41(4):433-8. PubMed ID: 668868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combined treatment of experimental silicotuberculosis with poly-2-vinylpyridine-N-oxide and isoniazid].
    Frolova NN; Ozerova LV; Mordovskoĭ GG
    Probl Tuberk; 1975; (3):67-9. PubMed ID: 1135207
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhibition of experimental silicosis by subcutaneous administration of polyvinylpyridine-N-oxide].
    SCHLIPKOETER HW; BROCKHAUS A
    Klin Wochenschr; 1961 Nov; 39():1182-9. PubMed ID: 14498575
    [No Abstract]   [Full Text] [Related]  

  • 34. Lysosomes and the toxicity of particulate pollutants.
    Allison AC
    Arch Intern Med; 1971 Jul; 128(1):131-9. PubMed ID: 4326019
    [No Abstract]   [Full Text] [Related]  

  • 35. [Polyvinylpyridine N-oxide (Bay 3504, P-204, PVNO) in the treatment of human silicosis].
    Prügger F; Mallner B; Schlipköter HW
    Wien Klin Wochenschr; 1984 Dec; 96(23):848-53. PubMed ID: 6396971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Decomposition of collagen in experimental silicosis following treatment with polyvinylpyridine-N-oxide in dependence on the dosage].
    Pott F; Dehnen W; Brockhaus A
    Beitr Klin Erforsch Tuberk Lungenkr; 1970; 140(3):259-67. PubMed ID: 4314381
    [No Abstract]   [Full Text] [Related]  

  • 37. The protective influence of polyvinylpyridine-N-oxide in experimental silicosis.
    Cavagna G; Nichelatti T
    Med Lav; 1963 Oct; 54(10):621-7. PubMed ID: 5878631
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current aspects of treatment of silicosis].
    Sidorova NV
    Sov Med; 1974 Aug; 0(8):39-43. PubMed ID: 4610803
    [No Abstract]   [Full Text] [Related]  

  • 39. [MORPHOLOGIC, FUNCTIONAL AND BIOCHEMICAL STUDIES ON THE EFFECT OF POLYVINYLPYRIDINE-N-OXIDE ON EXPERIMENTAL SILICOSIS].
    BECK EG; ANTWEILER H; SCHILLER E
    Grundfragen Silikoseforsch; 1963; 6():233-44. PubMed ID: 14338733
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antisilicosis activity of PVPO administered intratracheally and by inhalation (an experimental study)].
    Rodkina BS; Bolonova LN
    Gig Tr Prof Zabol; 1979 Sep; (9):32-6. PubMed ID: 535751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.